Stay updated with breaking news from Devasena Anantharaman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Uniindia: Thiruvananthapuram, Sep 4 (UNI) The Rajiv Gandhi Centre for Biotechnology (RGCB) is contributing significantly in determining the efficacy of Cervavax, India’s first indigenously developed vaccine for the prevention of cervical cancer, the second-most prevalent cancer among women in the country. <br /
Excelsior Correspondent NEW DELHI, Sept 1: Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today launched India’s first indigenously developed vaccine, “CERAVAC” for the prevention of Cervical Cancer. Announcing the scientific completion of the quadrivalent Human Papillomavirus (qHPV) vaccine in presence of Adar C. Poonawalla, CEO, Serum Institute of India, Pune and other prominent scientists and dignitaries,...
NEW DELHI, September 1 : Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today launched India’s first indigenously developed vaccine, “CERAVAC” for the prevention of Cervical Cancer. Announcing the scientific completion of the quadrivalent Human Papillomavirus (qHPV) vaccine in presence of Adar C. Poonawalla, CEO, Serum Institute of India, Pune and other prominent scientists and dignitaries, Dr Jitendra Singh […]